Medicine and Dentistry
Atrial Fibrillation
100%
Catheter Ablation
81%
Implantable Automatic Defibrillator
37%
Catheter Ablation
30%
Cardiac Resynchronization Therapy
27%
Atrioventricular Node
27%
Quality of Life
23%
Shock (Circulatory)
21%
Pulmonary Vein
19%
Health Care Cost
18%
Recurrent Disease
18%
Defibrillator
16%
Heart Left Ventricle Ejection Fraction
16%
Electrophysiology
15%
Symptom
15%
Radiation Exposure
14%
Pericardiocentesis
14%
Anatomy
14%
Fluoroscopy
14%
Patient Care
13%
Ophthalmology
13%
Irrigated-Tip Catheter Ablation
13%
Cell Saver
13%
Ischemic Cardiomyopathy
13%
Angiography
13%
Endocrine Ophthalmopathy
13%
Faintness
13%
Anticoagulation
13%
Persistent Atrial Fibrillation
13%
Heart Ventricle Arrhythmia
13%
Sudden Cardiac Death
13%
Placebo Effect
13%
Dilated Cardiomyopathy
13%
Elderly Patient
13%
Lead Fracture
13%
Ablation Therapy
12%
Electrography
10%
Great Arteries
9%
Cancer
9%
Blood Autotransfusion
8%
Pulmonary Vein Isolation
7%
Cardiac Dysrhythmia
7%
Clinician
6%
Radiation Therapy
6%
Rhythm
6%
Defibrillation
6%
Observational Study
6%
Ejection Fraction
5%
Atrial Fibrillation Ablation
5%
Apoplexy
5%
Keyphrases
Atrial Fibrillation
82%
Cardiac Resynchronization Therapy
40%
Atrial Fibrillation Ablation
29%
Ablation
29%
Atrioventricular Junction Ablation
27%
Right Ventricular Pacing
20%
Left Ventricular Ejection Fraction
19%
Randomized Trial
19%
Pharmacological Therapy
17%
Pulmonary Vein Isolation
16%
Implantable Cardioverter Defibrillator Lead
16%
Atrial Fibrillation Recurrence
16%
Cardiac Surgery
15%
Warfarin
15%
Implantable Defibrillator
14%
Contemporary Management
13%
Discrete Potentials
13%
Pericardiocentesis
13%
Impact on Care
13%
Syncope
13%
Differential Outcomes
13%
Syncope Unit
13%
Irrigated-tip Ablation
13%
Ablation Catheter
13%
Placebo-controlled Randomized Trial
13%
Health-related Costs
13%
Long-term Quality of Life
13%
Elderly Patients
13%
Invasive Management
13%
Cardiac Devices
13%
Bleeding Events
13%
Patient Health
13%
Cardiac Death
13%
Anticoagulation Management
13%
Oral Anticoagulant Therapy
13%
Abandoned Leads
13%
Arteriovenous
13%
Meta-analysis of Randomized Controlled Trials
13%
Cardiac Resynchronization
13%
Ischemic Cardiomyopathy
13%
Graves' Ophthalmopathy
13%
Recovery System
13%
Pulmonary Vein Angiography
13%
American Academy of Ophthalmology
13%
Progressive Heart Failure
13%
Outflow Tract Ventricular Arrhythmia
13%
Risk Factors
13%
Management Strategy
13%
Symptom Relief
13%
Placebo Effect
13%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
94%
Recurrent Disease
21%
Heart Arrhythmia
20%
Randomized Controlled Trial
20%
Heart Atrium Arrhythmia
16%
Anticoagulation Therapy
16%
Placebo
16%
Radiation Exposure
16%
Thromboembolism
13%
Persistent Atrial Fibrillation
13%
Endocrine Ophthalmopathy
13%
Faintness
13%
Heart Ventricle Arrhythmia
13%
Lead Fracture
13%
Atorvastatin
13%
Sudden Cardiac Death
13%
Heart Left Bundle Branch Block
13%
Warfarin
13%
Amiodarone
8%
Sotalol
8%
Beta Adrenergic Receptor Blocking Agent
8%
Atrioventricular Nodal Reentry Tachycardia
6%
Observational Study
6%
Heart Atrium Flutter
6%
Heart Ventricle Tachycardia
6%
All Cause Mortality
5%
Heparin
5%
Randomized Clinical Trial
5%
Effusion
5%